Order Article Reprints

Serio B, Storti G, D’Addona M, Santoro L, Frieri C, De Novellis D, Marano L, De Santis G, Guariglia R, Manfra I, et al. Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience. Hematology Reports. 2024; 16(2):234-243. https://doi.org/10.3390/hematolrep16020023

Serio, Bianca, Gabriella Storti, Matteo D’Addona, Lidia Santoro, Camilla Frieri, Danilo De Novellis, Luana Marano, Giovanna De Santis, Roberto Guariglia, Ilenia Manfra, and et al. 2024. "Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience" Hematology Reports 16, no. 2: 234-243. https://doi.org/10.3390/hematolrep16020023

Serio, B., Storti, G., D’Addona, M., Santoro, L., Frieri, C., De Novellis, D., Marano, L., De Santis, G., Guariglia, R., Manfra, I., Urciuoli, E., Luponio, S., Marotta, S., Morini, D., Rizzo, M., Palmieri, F., Cantore, N., Giudice, V., Risitano, A. M., & Selleri, C. (2024). Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience. Hematology Reports, 16(2), 234-243. https://doi.org/10.3390/hematolrep16020023